Prof Declan Murphy
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
804 Scholarly works
9 Projects
HIGHLIGHTS
2026
Journal article
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.
DOI: 10.1038/s41467-026-74255-x2026
Journal article
Long-term trends in androgen-directed therapy in advanced prostate cancer: a 29-year national analysis
DOI: 10.1007/s11255-026-05003-92026
Research grants (ARC, NHMRC, MRFF)
Unraveling Metastasis-Specific Immune Niches to Transform Cancer Treatment
2019
Research Grant
Up-Front Psma Alliance: Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Startegies for Psma-Negative Disease
2018
Journal article
Cold kit for prostate-Specific membrane antigen (PSMA) PET imaging: Phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
DOI: 10.2967/jnumed.117.1995542017
Conference Proceedings
Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA
DOI: 10.1093/annonc/mdx370.0022017
Research Grant
Biofocussed Prostate Cancer Radiotherapy (Birt): A Personalised Approach to Delivering the Right Dose to the Right Place
RECENT SCHOLARLY WORKS
2026
Journal article
A Multidisciplinary Approach to Prevention and Treatment of Late Genitourinary Adverse Events After Radiotherapy for Prostate Cancer.
DOI: 10.1016/j.eururo.2026.05.0082026
Journal article
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials
DOI: 10.1016/S1470-2045(26)00170-12026
Journal article
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study
DOI: 10.1016/S1470-2045(26)00091-42026
Journal article
Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomy
DOI: 10.1111/bju.703532026
Journal article
Neoadjuvant Treatment for Penile Cancer: A Systematic Review of Contemporary Evidence
DOI: 10.3390/cancers181015952026
Journal article
IP23-07 A CRITICAL APPRAISAL OF PSMA-PET USE FOR PRIMARY STAGING IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY: IS MOLECULAR IMAGING ALWAYS NEEDED?
DOI: 10.1097/01.ju.0001191400.40198.e5.072026
Journal article
IP73-13 REAL-WORLD DAROLUTAMIDE SAFETY AND EFFECTIVENESS IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) WITH COMORBIDITIES AND CONCOMITANT MEDICATIONS: POST HOC ANALYSES AT DAROL INTERIM ANALYSIS 4 (IA4)
DOI: 10.1097/01.ju.0001191728.67566.6d.132026
Journal article
Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial
DOI: 10.1016/j.euo.2024.11.006